Latest Retreatment Stories
DUBLIN, May 15, 2015 /PRNewswire/ -- Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), today announced that the U.S.
Data Show Recurrent Hand Contractures Treated Successfully in Nearly 90 Percent of Patients; Retreatment Shown to be Well-Tolerated CHESTERBROOK, Pa., Jan.
A new statistical review calls into question studies that have been taken as proof that antibiotic retreatment for chronic Lyme disease is futile.
Asymptomatic patients diagnosed with nonbulky follicular lymphoma, a slow-growing type of non-Hodgkin lymphoma, have traditionally been watched for signs or symptoms of disease progression and then treated with a combination of rituximab and chemotherapy or rituximab alone for select cases.
TUSTIN, Calif., May 31, 2011 /PRNewswire/ -- MicroVention-Terumo, Inc., a leader in developing, manufacturing and marketing interventional neurovascular devices, announced today the final 18-month follow-up data in a landmark international study.
The standard retreatment regimen for tuberculosis has low treatment response rates and is associated with poor long term outcomes in certain subgroups of patients, particularly those infected with both HIV and multi-drug resistant TB.
TUSTIN, Calif., Aug.
The risks associated with treating a recurrent or residual brain aneurysm that was initially treated by endovascular coiling are low, according to a multicenter study led by researchers at the University of Cincinnati (UC) Neuroscience Institute.
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.